Annual report pursuant to Section 13 and 15(d)

Schedule of Stock Awards Granted (Details)

v3.22.2.2
Schedule of Stock Awards Granted (Details)
12 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of Shares, Outstanding, Beginning balance | shares 604,404
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares $ 2.18
Number of Shares, Granted | shares 1,307,055
Weighted Average Exercise Price, Granted | $ / shares $ 5.76
Number of Shares, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Number of Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Number of Shares, Outstanding, Ending balance | shares 1,911,459
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares $ 4.63
Weighted Average Remaining Contractual Term (Years), Outstanding, Ending balance 4 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding, Ending balance | $ $ 2,625,173
Number of Shares, Exercisable, Ending balance | shares 304,914
Weighted Average Exercise Price, Exercisable, Ending balance | $ / shares $ 2.55
Weighted Average Remaining Contractual Term (Years), Exercisable, Ending balance 3 years 8 months 12 days
Aggregate Intrinsic Value, Exercisable, Ending balance | $ $ 848,665